Christine Tsingos's Trading History
| NVSTEnvista Holdings | May 21, 2026 | Director | Uninformative Buy | ― | $1.41M | |
| VREXVarex Imaging | Feb 09, 2026 | Director | Uninformative Buy | 119.10K | $786.13K | |
| ONTOOnto Innovation | May 23, 2024 | Director | Uninformative Buy | ― | $8.65M | |
| TBIOTelesis Bio | May 03, 2024 | Director | Uninformative Buy | ― | $1.04K | |
| BIOBio-Rad Laboratories | Dec 17, 2018 | EVP & CFO | Informative Sell | 349.93K | $2.49M |
You May Also Like
Christine Tsingos insider profile FAQ
What is the percentage of profitable transactions made by Christine Tsingos?
The percentage of profitable transactions made by Christine Tsingos is 17%.
What is the average return per transaction made by Christine Tsingos?
The average return per transaction made by Christine Tsingos is -23.10%.
What stocks does Christine Tsingos hold?
Christine Tsingos holds: NVST, BIO, VREX, TBIO, ONTO stocks.
What was Christine Tsingos's most profitable transaction?
Christine Tsingos’s most profitable transaction was an Informative Sell of BIO stock on December 14, 2017. The return on the trade was 0.70%.
What is Christine Tsingos's role in Envista Holdings?
Christine Tsingos's role in Envista Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.